-+ 0.00%
-+ 0.00%
-+ 0.00%

Is Dr. Ing. h.c. F. Porsche (XTRA:P911) Overpriced On Its 16% Delivery Decline?

Simply Wall St·07/22/2026 22:22:42
語音播報

Dr. Ing. h.c. F. Porsche (XTRA:P911) reported first half 2026 deliveries of 122,306 vehicles, down 16% from 146,391 a year earlier. The results put the company’s core demand and production trends in sharper focus for investors.

See our latest analysis for Dr. Ing. h.c. F. Porsche.

The first half delivery decline sits against a mixed share price picture for Dr. Ing. h.c. F. Porsche, with a 10.14% 90 day share price return contrasted by a 3 year total shareholder return that is down 52.85%. This suggests recent momentum but a weaker longer term record.

If this delivery update has you reconsidering where growth or resilience might come from, it could be a good time to broaden your search with 108 top founder-led companies

For Dr. Ing. h.c. F. Porsche, a 16% delivery decline set against a stronger recent share price invites two readings: a value opportunity after a tough stretch, or a stock pricing in more than current fundamentals support. Which does the data lean toward next?

Price-to-Earnings of 134.4x: Is it justified?

On the latest figures, Dr. Ing. h.c. F. Porsche trades at a P/E of 134.4x, which is high relative to many listed companies and sits against a last close of €46.16.

The P/E multiple compares the share price to earnings per share and is a quick way to see how much investors are paying for each unit of current earnings. For an established auto manufacturer like Dr. Ing. h.c. F. Porsche, such a high P/E suggests the market is putting a strong focus on future earnings potential rather than recent reported profits. Those recent profits include a large one off loss of €285.0m and profit margins of 0.9% that are lower than last year’s 8%.

Against that backdrop, the 134.4x P/E is far above the global auto industry average of 13.1x and also well above an estimated fair P/E of 18.8x derived from broader market relationships. It is also far higher than the peer average of 5.7x, which signals that the current price builds in much richer expectations than those implied for similar auto stocks. Some investors may see this as a level that the market could eventually move closer to if sentiment or earnings reset.

Explore the SWS fair ratio for Dr. Ing. h.c. F. Porsche

Result: Price-to-Earnings of 134.4x (OVERVALUED)

However, the 16% delivery decline and very low recent profit margin at Dr. Ing. h.c. F. Porsche could challenge such a rich P/E if sentiment shifts.

Find out about the key risks to this Dr. Ing. h.c. F. Porsche narrative.

Another view using the SWS DCF model

While the P/E of 134.4x suggests Dr. Ing. h.c. F. Porsche is richly priced, the SWS DCF model points in the same direction, with an estimated future cash flow value of €45.63 versus a market price of €46.16, indicating the stock is trading slightly above that mark. If earnings or sentiment soften, how much support does this DCF anchor really offer?

Look into how the SWS DCF model arrives at its fair value.

P911 Discounted Cash Flow as at Jul 2026
P911 Discounted Cash Flow as at Jul 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Dr. Ing. h.c. F. Porsche for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 238 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With sentiment on Dr. Ing. h.c. F. Porsche clearly mixed, take a moment to look through the numbers yourself and decide how you feel about the balance of risks and rewards. To weigh both sides in one place, start with the 1 key reward and 3 important warning signs

Looking for more investment ideas beyond Dr. Ing. h.c. F. Porsche?

If Dr. Ing. h.c. F. Porsche leaves you questioning what truly fits your portfolio, now is the moment to widen your watchlist with focused, data driven stock ideas.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.